Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
16.94
+0.46 (2.79%)
At close: Mar 6, 2026
Market Cap7.13B +124.7%
Revenue (ttm)720.67M +72.5%
Net Income-19.73M
EPS-0.05
Shares Out420.78M
PE Ration/a
Forward PE121.00
Dividendn/a
Ex-Dividend Daten/a
Volume8,759,201
Average Volume7,494,957
Open16.48
Previous Close16.48
Day's Range16.38 - 17.37
52-Week Range9.00 - 22.55
Beta0.49
RSI49.32
Earnings DateMar 31, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 683
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 720.67 million, an increase of 72.49% compared to the previous year's 417.80 million. Losses were -19.73 million, -86.02% less than in 2024.

Financial Statements